- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
University of Alabama at BirminghamGenentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Milton S. Hershey Medical CenterAvon FoundationCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Western Regional Medical CenterTerminated
-
University of PittsburghWithdrawnBreast Cancer FemaleUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
AgennixCompleted
-
Cancer Research NetworkHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
CytoDyn, Inc.WEP ClinicalAvailableTNBC, Triple Negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | TNBCUnited States
-
Joseph SparanoCompletedBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Anthracycline-refractory TNBCUnited States
-
Northwestern UniversityLynn Sage FoundationCompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Burzynski Research InstituteWithdrawnStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast AdenocarcinomaUnited States
-
University of WashingtonTerminatedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Jonsson Comprehensive Cancer CenterNovartis; Seagen Inc.Active, not recruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Center for Advancing Translational Sciences (NCATS)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte CorporationNot yet recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte CorporationRecruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Localized Estrogen Receptor-Positive Breast Carcinoma | Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterTranslational Breast Cancer Research Consortium; Breast Cancer Research Foundation and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonMerck Sharp & Dohme LLCWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedDuctal Breast Carcinoma in Situ | Breast Cancer, Stage I | Breast Cancer, Stage II | Breast Cancer, Stage IIIUnited States
-
University of California, DavisRecruitingBreast Cancer | Ovarian Cancer | Breast Neoplasm | Breast Carcinoma | Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II | Invasive Breast Cancer | Cancer, Breast | Breast Cancer Stage III | Ovary Cancer | Malignant Tumor of Breast | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Ovarian Cancer... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | Paget Disease of the Breast | Benign Breast NeoplasmUnited States
-
University of Alabama at BirminghamEnrolling by invitationBreast Cancer Early Stage Breast Cancer (Stage 1-3)United States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
Genta IncorporatedUnknownMetastatic Breast Cancer | Locally Advanced Non-resectable Breast CancerUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor Positive Breast Carcinoma | Breast Ductal Carcinoma in Situ | HER2 Negative Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Hormone Receptor-Positive Breast Carcinoma | Unresectable Hormone Receptor-Positive Breast Carcinoma | Advanced Hormone Receptor-Positive Breast CarcinomaUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOverweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer... and other conditionsUnited States
-
Prescient Therapeutics, Ltd.National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Breast AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterSuspended
-
Washington University School of MedicineTerminatedBreast Cancer | Cancer of Breast | Cancer of the BreastUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma In SituUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterCity of Hope Medical Center; The New School for Social ResearchActive, not recruitingBreast Cancer SurvivorsUnited States
-
Translational Drug DevelopmentSide-Out FoundationCompletedMetastatic Breast CancerUnited States
-
Georgetown UniversityUnknownBreast Cancer FemaleUnited States
-
Northwell HealthDepYmed Inc.TerminatedMetastatic Breast CancerUnited States
-
George Albert FisherSanofi; GlaxoSmithKlineCompletedBreast Cancer | Metastatic Breast CancerUnited States